Operation of ‘Samsung Biologics 5 Factory’ to be advanced by 5 months
폴 리
hoondork1977@alphabiz.co.kr | 2023-06-07 03:00:07
[Alpha Biz=(Chicago) Reporter Paul Lee] John Lim, CEO of Samsung BioLogics, said, "We have moved up the target operation of the fifth plant scheduled for September 2025 by five months to April."
"We started construction of our fifth plant in Songdo in April," CEO John Lim said at a CEO press conference at the Sea Port District in Westin Boston on the 5th (local time). If the operation takes place early, the fifth plant will be completed about a year earlier than the third plant of the same size.
Samsung BioLogics previously held a board meeting in March and decided to expand its fifth plant with an annual area of 96,000㎡ with a total investment of 1.98 trillion won by September 2025. "We are trying to operate faster because orders are coming in well," CEO John Lim added.
The construction of the second bio campus has also begun in earnest with the early construction of the fifth plant. The campus will have four 180,000-liter plants, starting with the fifth plant.
[ⓒ AlphaBIZ. 무단전재-재배포 금지]
많이 본 기사
- 1NH Investment & Securities Cuts NAVER Target Price to KRW 320,000, Maintains ‘Buy’ on AI Growth Outlook
- 2Korean Air and LCC Affiliates Enter Emergency Management as Fuel Costs Surge Amid Middle East Conflict
- 3Lotte Group to Launch KRW 50 Trillion Real Estate Development Push to Tackle Liquidity Pressures
- 4Amazon Web Services to Invest KRW 7 Trillion More in Korea by 2031, Expanding AI Infrastructure
- 5China Vanke Posts Record Loss as Property Slump Deepens Financial Strain
- 6Daesang Executive Arrested in KRW 10 Trillion Sweetener Price-Fixing Probe; CEOs Avoid Detention